Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 362

1.

The Reconstructed Cohort Design: A Method to Study Rare Neurodegenerative Diseases in Population-Based Settings.

Logroscino G, Kurth T, Piccininni M.

Neuroepidemiology. 2020 Jan 7:1-9. doi: 10.1159/000502863. [Epub ahead of print]

PMID:
31910416
2.

Corrigendum to "Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: A systematic review" Neurosci. Biobehav. Rev. 95 (2018) 480-498.

Solfrizzi V, Agosti P, Lozupone M, Custodero C, Schilardi A, Valiani V, Santamato A, Sardone R, Dibello V, Di Lena L, Stallone R, Ranieri M, Bellomo A, Greco A, Daniele A, Seripa D, Sabbà C, Logroscino G, Panza F.

Neurosci Biobehav Rev. 2020 Jan;108:889. doi: 10.1016/j.neubiorev.2019.11.022. Epub 2019 Dec 5. No abstract available.

PMID:
31812282
3.

Incidence of dementia in the oldest-old and its relationship with age: The Monzino 80-plus population-based study.

Lucca U, Tettamanti M, Tiraboschi P, Logroscino G, Landi C, Sacco L, Garrì M, Ammesso S, Biotti A, Gargantini E, Piedicorcia A, Mandelli S, Riva E, Galbussera AA, Recchia A.

Alzheimers Dement. 2019 Nov 27. pii: S1552-5260(19)35483-4. doi: 10.1016/j.jalz.2019.09.083. [Epub ahead of print]

PMID:
31786127
4.

Sensorial frailty: age-related hearing loss and the risk of cognitive impairment and dementia in later life.

Panza F, Lozupone M, Sardone R, Battista P, Piccininni M, Dibello V, La Montagna M, Stallone R, Venezia P, Liguori A, Giannelli G, Bellomo A, Greco A, Daniele A, Seripa D, Quaranta N, Logroscino G.

Ther Adv Chronic Dis. 2018 Nov 9;10:2040622318811000. doi: 10.1177/2040622318811000. eCollection 2019. Review.

5.

Effect modification of the association between total cigarette smoking and ALS risk by intensity, duration and time-since-quitting: Euro-MOTOR.

Peters S, Visser AE, D'Ovidio F, Vlaanderen J, Portengen L, Beghi E, Chio A, Logroscino G, Hardiman O, Pupillo E, Veldink JH, Vermeulen R, van den Berg LH; Euro-MOTOR consortium.

J Neurol Neurosurg Psychiatry. 2020 Jan;91(1):33-39. doi: 10.1136/jnnp-2019-320986. Epub 2019 Aug 21.

PMID:
31434759
6.

Biopsychosocial frailty and the risk of incident dementia: The Italian longitudinal study on aging.

Solfrizzi V, Scafato E, Lozupone M, Seripa D, Schilardi A, Custodero C, Sardone R, Galluzzo L, Gandin C, Baldereschi M, Di Carlo A, Inzitari D, Giannelli G, Daniele A, Sabbà C, Logroscino G, Panza F; Italian Longitudinal Study on Aging Working Group.

Alzheimers Dement. 2019 Aug;15(8):1019-1028. doi: 10.1016/j.jalz.2019.04.013. Epub 2019 Jul 2.

PMID:
31278052
7.

The Age-Related Central Auditory Processing Disorder: Silent Impairment of the Cognitive Ear.

Sardone R, Battista P, Panza F, Lozupone M, Griseta C, Castellana F, Capozzo R, Ruccia M, Resta E, Seripa D, Logroscino G, Quaranta N.

Front Neurosci. 2019 Jun 14;13:619. doi: 10.3389/fnins.2019.00619. eCollection 2019. Review.

8.

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis.

Bridel C, van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE; and the NFL Group, Alvarez-Cermeño JC, Andreasson U, Axelsson M, Bäckström DC, Bartos A, Bjerke M, Blennow K, Boxer A, Brundin L, Burman J, Christensen T, Fialová L, Forsgren L, Frederiksen JL, Gisslén M, Gray E, Gunnarsson M, Hall S, Hansson O, Herbert MK, Jakobsson J, Jessen-Krut J, Janelidze S, Johannsson G, Jonsson M, Kappos L, Khademi M, Khalil M, Kuhle J, Landén M, Leinonen V, Logroscino G, Lu CH, Lycke J, Magdalinou NK, Malaspina A, Mattsson N, Meeter LH, Mehta SR, Modvig S, Olsson T, Paterson RW, Pérez-Santiago J, Piehl F, Pijnenburg YAL, Pyykkö OT, Ragnarsson O, Rojas JC, Romme Christensen J, Sandberg L, Scherling CS, Schott JM, Sellebjerg FT, Simone IL, Skillbäck T, Stilund M, Sundström P, Svenningsson A, Tortelli R, Tortorella C, Trentini A, Troiano M, Turner MR, van Swieten JC, Vågberg M, Verbeek MM, Villar LM, Visser PJ, Wallin A, Weiss A, Wikkelsø C, Wild EJ.

JAMA Neurol. 2019 Jun 17. doi: 10.1001/jamaneurol.2019.1534. [Epub ahead of print]

PMID:
31206160
9.

Arthroscopy in osteochondral pathology of the elbow: indications, treatment and complications.

XIX CONGRESSO NAZIONALE S.I.C.O.O.P. SOCIETA' ITALIANA CHIRURGHI ORTOPEDICI DELL'OSPEDALITA' PRIVATA ACCREDITATA, Logroscino G, Saracco M, Goderecci R, Paglia A, Calvisi V.

J Biol Regul Homeost Agents. 2019 Mar-Apr;33(2 Suppl. 1):1-7. Review.

PMID:
31168996
10.

Associations of Cognitive Function and Education Level With All-Cause Mortality in Adults on Hemodialysis: Findings From the COGNITIVE-HD Study.

van Zwieten A, Wong G, Ruospo M, Palmer SC, Teixeira-Pinto A, Barulli MR, Iurillo A, Saglimbene V, Natale P, Gargano L, Murgo M, Loy CT, Tortelli R, Craig JC, Johnson DW, Tonelli M, Hegbrant J, Wollheim C, Logroscino G, Strippoli GFM; COGNITIVE-HD Study Investigators.

Am J Kidney Dis. 2019 Oct;74(4):452-462. doi: 10.1053/j.ajkd.2019.03.424. Epub 2019 Jun 1.

PMID:
31160141
11.

Comparative Analysis of C9orf72 and Sporadic Disease in a Large Multicenter ALS Population: The Effect of Male Sex on Survival of C9orf72 Positive Patients.

Trojsi F, Siciliano M, Femiano C, Santangelo G, Lunetta C, Calvo A, Moglia C, Marinou K, Ticozzi N, Ferro C, Scialò C, Sorarù G, Conte A, Falzone YM, Tortelli R, Russo M, Sansone VA, Chiò A, Mora G, Silani V, Volanti P, Caponnetto C, Querin G, Sabatelli M, Riva N, Logroscino G, Messina S, Fasano A, Monsurrò MR, Tedeschi G, Mandrioli J.

Front Neurosci. 2019 May 17;13:485. doi: 10.3389/fnins.2019.00485. eCollection 2019.

12.

Early pathological gambling in co-occurrence with semantic variant primary progressive aphasia: a case report.

Battista P, Capozzo R, Rizzo G, Zecca C, Anastasia A, De Blasi R, Logroscino G.

Clin Interv Aging. 2019 Apr 26;14:727-733. doi: 10.2147/CIA.S197484. eCollection 2019.

13.

Recurrent postoperative delirium in spinocerebellar ataxia type 2: a case report.

Levantesi L, De Cosmo G, Logroscino G, Saracco M.

J Med Case Rep. 2019 Apr 29;13(1):112. doi: 10.1186/s13256-019-2040-9.

14.

Episodic memory and learning rates in amyotrophic lateral sclerosis without dementia.

Barulli MR, Piccininni M, Di Dio C, Musarò C, Grasso A, Tursi M, Iurillo A, Lozupone M, Capozzo R, Tortelli R, Simone IL, Panza F, Logroscino G.

Cortex. 2019 Aug;117:257-265. doi: 10.1016/j.cortex.2019.03.003. Epub 2019 Mar 19.

PMID:
31005026
15.

Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs.

Logroscino G, Imbimbo BP, Lozupone M, Sardone R, Capozzo R, Battista P, Zecca C, Dibello V, Giannelli G, Bellomo A, Greco A, Daniele A, Seripa D, Panza F.

Expert Opin Pharmacother. 2019 Jun;20(9):1091-1107. doi: 10.1080/14656566.2019.1598377. Epub 2019 Apr 19. Review.

PMID:
31002267
16.

Incidence of frontotemporal lobar degeneration in Italy: The Salento-Brescia Registry study.

Logroscino G, Piccininni M, Binetti G, Zecca C, Turrone R, Capozzo R, Tortelli R, Battista P, Bagoj E, Barone R, Fostinelli S, Benussi L, Ghidoni R, Padovani A, Cappa SF, Alberici A, Borroni B.

Neurology. 2019 May 14;92(20):e2355-e2363. doi: 10.1212/WNL.0000000000007498. Epub 2019 Apr 12. Erratum in: Neurology. 2019 Sep 24;93(13):608.

PMID:
30979859
17.

Risk factors for failure of two-stage revision arthroplasty for infected hip prosthesis: review of the literature and single centre cohort analysis.

Logroscino G, Campana V, Pagano S, Taccari F, Fantoni M, Saracco M.

Eur Rev Med Pharmacol Sci. 2019 Apr;23(2 Suppl):65-75. doi: 10.26355/eurrev_201904_17476.

18.

Disease-modifying therapies for tauopathies: agents in the pipeline.

Panza F, Imbimbo BP, Lozupone M, Greco A, Seripa D, Logroscino G, Daniele A, Colosimo C.

Expert Rev Neurother. 2019 May;19(5):397-408. doi: 10.1080/14737175.2019.1606715. Epub 2019 Apr 25.

PMID:
30973276
19.

Amyotrophic lateral sclerosis mortality rates among ethnic groups in a predominant admixed population in Latin America: a population-based study in Ecuador.

Luna J, Preux PM, Logroscino G, Erazo D, Del Brutto OH, Boumediene F, Couratier P, Marin B.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Aug;20(5-6):404-412. doi: 10.1080/21678421.2019.1587632. Epub 2019 Apr 2.

PMID:
30938194
20.

Multicentre, population-based, case-control study of particulates, combustion products and amyotrophic lateral sclerosis risk.

Visser AE, D'Ovidio F, Peters S, Vermeulen RC, Beghi E, Chiò A, Veldink JH, Logroscino G, Hardiman O, van den Berg LH; Euro-MOTOR consortium.

J Neurol Neurosurg Psychiatry. 2019 Aug;90(8):854-860. doi: 10.1136/jnnp-2018-319779. Epub 2019 Mar 8.

PMID:
30850472
21.

Comparison of the clinical and genetic features of amyotrophic lateral sclerosis across Cuban, Uruguayan and Irish clinic-based populations.

Ryan M, Zaldívar Vaillant T, McLaughlin RL, Doherty MA, Rooney J, Heverin M, Gutierrez J, Lara-Fernández GE, Pita Rodríguez M, Hackembruch J, Perna A, Vazquez MC, Musio M, Ketzoian CN, Logroscino G, Hardiman O.

J Neurol Neurosurg Psychiatry. 2019 Jun;90(6):659-665. doi: 10.1136/jnnp-2018-319838. Epub 2019 Mar 7.

PMID:
30846540
22.

Comparative evaluation of two immunoassays for cerebrospinal fluid β-Amyloid1-42 measurement.

Zecca C, Brescia V, Piccininni M, Capozzo R, Barone R, Barulli MR, Logroscino G.

Clin Chim Acta. 2019 Jun;493:107-111. doi: 10.1016/j.cca.2019.02.033. Epub 2019 Mar 4.

PMID:
30844363
23.

Anticholinergic burden before and after hospitalization in older adults with dementia: Increase due to antipsychotic medications.

Reinold J, Palese F, Romanese F, Logroscino G, Riedel O, Pisa FE.

Int J Geriatr Psychiatry. 2019 Jun;34(6):868-880. doi: 10.1002/gps.5084. Epub 2019 Mar 27.

PMID:
30761624
24.

Stemless hip arthroplasty versus traditional implants: a comparative observational study at 30 months follow-up.

Logroscino G, Donati F, Campana V, Saracco M.

Hip Int. 2018 Nov;28(2_suppl):21-27. doi: 10.1177/1120700018813209.

PMID:
30755116
25.

The Role of Biomarkers in Psychiatry.

Lozupone M, La Montagna M, D'Urso F, Daniele A, Greco A, Seripa D, Logroscino G, Bellomo A, Panza F.

Adv Exp Med Biol. 2019;1118:135-162. doi: 10.1007/978-3-030-05542-4_7. Review.

PMID:
30747421
26.

Are antibodies directed against amyloid-β (Aβ) oligomers the last call for the Aβ hypothesis of Alzheimer's disease?

Panza F, Lozupone M, Dibello V, Greco A, Daniele A, Seripa D, Logroscino G, Imbimbo BP.

Immunotherapy. 2019 Jan;11(1):3-6. doi: 10.2217/imt-2018-0119. Review. No abstract available.

27.

Understanding frailty to predict and prevent dementia.

Panza F, Lozupone M, Logroscino G.

Lancet Neurol. 2019 Feb;18(2):133-134. doi: 10.1016/S1474-4422(18)30446-0. No abstract available.

PMID:
30663601
28.

Predictors of diagnostic delay in amyotrophic lateral sclerosis: a cohort study based on administrative and electronic medical records data.

Palese F, Sartori A, Logroscino G, Pisa FE.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 May;20(3-4):176-185. doi: 10.1080/21678421.2018.1550517. Epub 2019 Jan 18.

PMID:
30656971
29.

Associations of Electric Shock and Extremely Low-Frequency Magnetic Field Exposure With the Risk of Amyotrophic Lateral Sclerosis.

Peters S, Visser AE, D'Ovidio F, Beghi E, Chiò A, Logroscino G, Hardiman O, Kromhout H, Huss A, Veldink J, Vermeulen R, van den Berg LH; Euro-MOTOR Consortium.

Am J Epidemiol. 2019 Apr 1;188(4):796-805. doi: 10.1093/aje/kwy287.

PMID:
30649156
30.

A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease.

Panza F, Lozupone M, Logroscino G, Imbimbo BP.

Nat Rev Neurol. 2019 Feb;15(2):73-88. doi: 10.1038/s41582-018-0116-6. Review.

PMID:
30610216
31.

Amyotrophic Lateral Sclerosis Descriptive Epidemiology: The Origin of Geographic Difference.

Logroscino G, Piccininni M.

Neuroepidemiology. 2019;52(1-2):93-103. doi: 10.1159/000493386. Epub 2019 Jan 2. Review.

32.

Loss of Swallow Tail Sign on Susceptibility-Weighted Imaging in Dementia with Lewy Bodies.

Rizzo G, De Blasi R, Capozzo R, Tortelli R, Barulli MR, Liguori R, Grasso D, Logroscino G.

J Alzheimers Dis. 2019;67(1):61-65. doi: 10.3233/JAD-180687.

PMID:
30475767
33.

Response to Letter to the Editor: "Plasma β-amyloid1-42 reference values".

Zecca C, Brescia V, Panza F, Logroscino G.

J Neurol Sci. 2019 Jan 15;396:123-124. doi: 10.1016/j.jns.2018.11.012. Epub 2018 Nov 9. No abstract available.

PMID:
30453206
34.

Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: A systematic review.

Solfrizzi V, Agosti P, Lozupone M, Custodero C, Schilardi A, Valiani V, Santamato A, Sardone R, Dibello V, Di Lena L, Stallone R, Ranieri M, Bellomo A, Greco A, Daniele A, Seripa D, Sabbà C, Logroscino G, Panza F.

Neurosci Biobehav Rev. 2018 Dec;95:480-498. doi: 10.1016/j.neubiorev.2018.10.022. Epub 2018 Nov 3. Erratum in: Neurosci Biobehav Rev. 2020 Jan;108:889.

PMID:
30395922
35.

Screening for Aphasia in NeuroDegeneration for the Diagnosis of Patients with Primary Progressive Aphasia: Clinical Validity and Psychometric Properties.

Battista P, Catricalà E, Piccininni M, Copetti M, Esposito V, Polito C, Miozzo A, Gobbi E, Cuoco S, Boschi V, Picillo M, Sorbi S, Barone P, Iannaccone S, Garrard P, Logroscino G, Cappa SF.

Dement Geriatr Cogn Disord. 2018;46(3-4):243-252. doi: 10.1159/000492632. Epub 2018 Oct 23.

PMID:
30352431
36.

Early failure of a locked titanium plate in a proximal humeral fracture: Case report and metallurgic analysis.

Logroscino G, Donati F, Saracco M, Pilloni L, Piconi C.

Trauma Case Rep. 2018 Oct 3;17:18-22. doi: 10.1016/j.tcr.2018.09.005. eCollection 2018 Oct.

37.

BACE inhibitors in clinical development for the treatment of Alzheimer's disease.

Panza F, Lozupone M, Solfrizzi V, Sardone R, Piccininni C, Dibello V, Stallone R, Giannelli G, Bellomo A, Greco A, Daniele A, Seripa D, Logroscino G, Imbimbo BP.

Expert Rev Neurother. 2018 Nov;18(11):847-857. doi: 10.1080/14737175.2018.1531706. Epub 2018 Oct 24.

PMID:
30277096
38.

CYP2D6 genotypes in revolving door patients with bipolar disorders: A case series.

Seripa D, Lozupone M, Miscio G, Stella E, La Montagna M, Gravina C, Urbano M, di Mauro L, Daniele A, Greco A, Logroscino G, Panza F, Bellomo A.

Medicine (Baltimore). 2018 Sep;97(37):e11998. doi: 10.1097/MD.0000000000011998.

39.

Plasma β-amyloid1-42 reference values in cognitively normal subjects.

Zecca C, Tortelli R, Panza F, Arcuti S, Piccininni M, Capozzo R, Barulli MR, Barone R, Cardinali R, Abbrescia D, Seripa D, Brescia V, Logroscino G.

J Neurol Sci. 2018 Aug 15;391:120-126. doi: 10.1016/j.jns.2018.06.006. Epub 2018 Jun 13.

PMID:
30103961
40.

Social Dysfunction in Older Age and Relationships with Cognition, Depression, and Apathy: The GreatAGE Study.

Lozupone M, Panza F, Piccininni M, Copetti M, Sardone R, Imbimbo BP, Stella E, D'Urso F, Barulli MR, Battista P, Grasso A, Tortelli R, Capozzo R, Coppola F, Abbrescia DI, Bellomo A, Giannelli G, Quaranta N, Seripa D, Logroscino G.

J Alzheimers Dis. 2018;65(3):989-1000. doi: 10.3233/JAD-180466.

PMID:
30103335
41.

Association between alcohol exposure and the risk of amyotrophic lateral sclerosis in the Euro-MOTOR study.

D'Ovidio F, Rooney JPK, Visser AE, Manera U, Beghi E, Logroscino G, Vermeulen RCH, Veldink JH, van den Berg LH, Hardiman O, Chiò A; Euro-MOTOR consortium.

J Neurol Neurosurg Psychiatry. 2019 Jan;90(1):11-19. doi: 10.1136/jnnp-2018-318559. Epub 2018 Aug 3.

PMID:
30076269
42.

How complete is the information on preadmission psychotropic medications in inpatients with dementia? A comparison of hospital medical records with dispensing data.

Pisa FE, Palese F, Romanese F, Barbone F, Logroscino G, Riedel O.

Int J Methods Psychiatr Res. 2018 Dec;27(4):e1724. doi: 10.1002/mpr.1724. Epub 2018 Jun 5.

PMID:
29869820
43.

Clinical features and genetic characterization of two dizygotic twins with C9orf72 expansion.

Conforti FL, Tortelli R, Morello G, Capozzo R, Barulli MR, Cavallaro S, Logroscino G.

Neurobiol Aging. 2018 Sep;69:293.e1-293.e8. doi: 10.1016/j.neurobiolaging.2018.05.002. Epub 2018 Jun 14.

PMID:
29866399
44.

Nutritional Intervention as a Preventive Approach for Cognitive-Related Outcomes in Cognitively Healthy Older Adults: A Systematic Review.

Solfrizzi V, Agosti P, Lozupone M, Custodero C, Schilardi A, Valiani V, Sardone R, Dibello V, Di Lena L, Lamanna A, Stallone R, Bellomo A, Greco A, Daniele A, Seripa D, Sabbà C, Logroscino G, Panza F.

J Alzheimers Dis. 2018;64(s1):S229-S254. doi: 10.3233/JAD-179940.

PMID:
29865058
45.

Pharmacotherapy for the treatment of depression in patients with alzheimer's disease: a treatment-resistant depressive disorder.

Lozupone M, La Montagna M, D'Urso F, Piccininni C, Sardone R, Dibello V, Giannelli G, Solfrizzi V, Greco A, Daniele A, Quaranta N, Seripa D, Bellomo A, Logroscino G, Panza F.

Expert Opin Pharmacother. 2018 Jun;19(8):823-842. doi: 10.1080/14656566.2018.1471136. Epub 2018 May 4. Review.

PMID:
29726758
46.

Age-specific ALS incidence: a dose-response meta-analysis.

Marin B, Fontana A, Arcuti S, Copetti M, Boumédiene F, Couratier P, Beghi E, Preux PM, Logroscino G.

Eur J Epidemiol. 2018 Jul;33(7):621-634. doi: 10.1007/s10654-018-0392-x. Epub 2018 Apr 23.

PMID:
29687175
47.

Multicentre, cross-cultural, population-based, case-control study of physical activity as risk factor for amyotrophic lateral sclerosis.

Visser AE, Rooney JPK, D'Ovidio F, Westeneng HJ, Vermeulen RCH, Beghi E, Chiò A, Logroscino G, Hardiman O, Veldink JH, van den Berg LH; Euro-MOTOR consortium.

J Neurol Neurosurg Psychiatry. 2018 Aug;89(8):797-803. doi: 10.1136/jnnp-2017-317724. Epub 2018 Apr 23.

PMID:
29685899
48.

Referral bias in ALS epidemiological studies.

Logroscino G, Marin B, Piccininni M, Arcuti S, Chiò A, Hardiman O, Rooney J, Zoccolella S, Couratier P, Preux PM, Beghi E; for EURALS.

PLoS One. 2018 Apr 16;13(4):e0195821. doi: 10.1371/journal.pone.0195821. eCollection 2018.

49.

Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to Prevention.

Panza F, Lozupone M, Solfrizzi V, Sardone R, Dibello V, Di Lena L, D'Urso F, Stallone R, Petruzzi M, Giannelli G, Quaranta N, Bellomo A, Greco A, Daniele A, Seripa D, Logroscino G.

J Alzheimers Dis. 2018;62(3):993-1012. doi: 10.3233/JAD-170963. Review.

50.

Pseudobulbar affect as a negative prognostic indicator in amyotrophic lateral sclerosis.

Tortelli R, Arcuti S, Copetti M, Barone R, Zecca C, Capozzo R, Barulli MR, Simone IL, Logroscino G.

Acta Neurol Scand. 2018 Jul;138(1):55-61. doi: 10.1111/ane.12918. Epub 2018 Mar 11.

PMID:
29527672

Supplemental Content

Loading ...
Support Center